Our partner James Tumbridge is a key note speaker at the forthcoming SEBC. It will be pre-recorded, and available for viewing by registered delegates from 08:00 – 20:00 BST on Wednesday 27 May 2020.
Oliver Pumfrey, Managing Director – FTI Consulting
Carole Pugh, Managing Director, EUDRAC
An update on the post Brexit regulatory framework, including what these new regulations mean for life sciences innovation, how it will help to accelerate research and ultimately benefit patients.
James Tumbridge, Partner, Barrister, Venner Shipley
An update on how changes in IP legislation and bureaucracy post Brexit can create opportunities for the industry
Shawn Manning, Managing Director, Akesios Associates.
An update on the Life Sciences funding landscape post Brexit. What changes might we expect and what will be the likely impact to the existing UK ecosystem?
To sign up click here.
James is a partner in our legal services team. He has extensive experience in commercial litigation, intellectual property and alternative dispute resolution (ADR). He is a member of the firm’s AI practice group.